Ms Mariana Ruiz Silva
Research Associate

Ms Mariana Ruiz Silva

BSc, MSc, PhD

Medicine & Health
The Kirby Institute

Mariana graduated in Pharmaceutical and Biological Chemistry from the Universidad Nacional Autonoma de Mexico. She holds a MSc in Medical and Pharmaceutical Drug Innovation from the Rijksuniversiteit Groningen (RUG) in The Netherlands. She received a PhD in virology from the RUG for the study of the innate immune response to dengue and chikungunya virus (co)-infections. After moving to Australia, she worked as a research assistant for NSW Health and UNSW performing whole genome sequencing of SARS-CoV-2. In 2021, Mariana joined the Kirby Institute to investigate the pathogenesis of SARS-CoV-2. She has experience working with viruses in a Biosafety level 3 lab, TIRF microscopy and next-generation sequencing.  

Phone
+61-2-93480776
Location
Level 5, Wallace Wurth Building, UNSW Sydney NSW 2052
  • Journal articles | 2022
    Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Stella AO; Kindinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Jean T; Foster CSP; Christ D; Hoppe AC; Munier ML; Darley D; Churchill M; Stark DJ; Matthews G; Rawlinson WD; Kelleher AD; Turville SG, 2022, 'SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern', eBioMedicine, vol. 84, pp. 104270, http://dx.doi.org/10.1016/j.ebiom.2022.104270

2016 Jan Kornelis de Cock Foundation Grant

2010 Mexican National Council for Science and Technology (CONACyT) Scholarship

2010 Medical and Pharmaceutical Drug Innovation (MPDI) Scholarship

SARS-CoV-2 pathogenesis